FDA 483 - Hetero Labs Limited - Unit III - October 26, 2016

Hetero Labs, Ltd. - Unit III received a Form 483 for significant deficiencies in laboratory controls and record-keeping. The firm failed to use validated and transferred analytical methods for various product testing stages and did not adequately investigate out-of-trend results. Additionally, laboratory records were incomplete and lacked proper documentation practices.